nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—CYP1A1—Clobetasol propionate—psoriasis	0.0619	0.0809	CbGbCtD
Quinidine—CYP1A1—Methoxsalen—psoriasis	0.0325	0.0425	CbGbCtD
Quinidine—ABCB11—Cyclosporine—psoriasis	0.0322	0.0422	CbGbCtD
Quinidine—CYP2C8—Tazarotene—psoriasis	0.0291	0.0381	CbGbCtD
Quinidine—CYP1A2—Clobetasol propionate—psoriasis	0.0276	0.0362	CbGbCtD
Quinidine—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0255	0.0333	CbGbCtD
Quinidine—SLCO1A2—Prednisolone—psoriasis	0.0228	0.0299	CbGbCtD
Quinidine—ABCC2—Mycophenolate mofetil—psoriasis	0.0224	0.0293	CbGbCtD
Quinidine—SLCO1A2—Hydrocortisone—psoriasis	0.0217	0.0283	CbGbCtD
Quinidine—SLCO1A2—Prednisone—psoriasis	0.0216	0.0282	CbGbCtD
Quinidine—CYP1A1—Cholecalciferol—psoriasis	0.0215	0.0282	CbGbCtD
Quinidine—ABCB11—Dexamethasone—psoriasis	0.0212	0.0278	CbGbCtD
Quinidine—SLCO1A2—Cyclosporine—psoriasis	0.0204	0.0268	CbGbCtD
Quinidine—SLCO1B1—Cyclosporine—psoriasis	0.0193	0.0252	CbGbCtD
Quinidine—ABCC2—Cyclosporine—psoriasis	0.017	0.0222	CbGbCtD
Quinidine—CYP2B6—Cholecalciferol—psoriasis	0.0164	0.0215	CbGbCtD
Quinidine—CYP1A2—Methoxsalen—psoriasis	0.0145	0.019	CbGbCtD
Quinidine—SLCO1A2—Dexamethasone—psoriasis	0.0135	0.0176	CbGbCtD
Quinidine—CYP2D6—Hydroxyurea—psoriasis	0.0131	0.0171	CbGbCtD
Quinidine—CYP2C8—Cholecalciferol—psoriasis	0.0124	0.0163	CbGbCtD
Quinidine—CYP3A7—Hydrocortisone—psoriasis	0.012	0.0157	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.012	0.0157	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0113	0.0148	CbGbCtD
Quinidine—CYP3A7—Cyclosporine—psoriasis	0.0113	0.0148	CbGbCtD
Quinidine—ABCC2—Dexamethasone—psoriasis	0.0112	0.0146	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—psoriasis	0.0108	0.0142	CbGbCtD
Quinidine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0108	0.0141	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—psoriasis	0.0102	0.0134	CbGbCtD
Quinidine—CYP3A4—Calcitriol—psoriasis	0.00978	0.0128	CbGbCtD
Quinidine—SLC22A8—Methotrexate—psoriasis	0.00942	0.0123	CbGbCtD
Quinidine—CYP1A1—Dexamethasone—psoriasis	0.00932	0.0122	CbGbCtD
Quinidine—ABCC2—Methotrexate—psoriasis	0.00897	0.0117	CbGbCtD
Quinidine—CYP2C9—Cholecalciferol—psoriasis	0.00867	0.0113	CbGbCtD
Quinidine—CYP2C8—Hydrocortisone—psoriasis	0.00864	0.0113	CbGbCtD
Quinidine—CYP2C8—Cyclosporine—psoriasis	0.00816	0.0107	CbGbCtD
Quinidine—CYP2D6—Cholecalciferol—psoriasis	0.00792	0.0104	CbGbCtD
Quinidine—CYP3A4—Methoxsalen—psoriasis	0.00761	0.00995	CbGbCtD
Quinidine—CYP3A7—Dexamethasone—psoriasis	0.00745	0.00975	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00745	0.00975	CbGbCtD
Quinidine—ABCB1—Mycophenolate mofetil—psoriasis	0.00729	0.00954	CbGbCtD
Quinidine—CYP2E1—Dexamethasone—psoriasis	0.0072	0.00941	CbGbCtD
Quinidine—CYP2B6—Dexamethasone—psoriasis	0.0071	0.00929	CbGbCtD
Quinidine—ABCB1—Betamethasone—psoriasis	0.00626	0.00818	CbGbCtD
Quinidine—ABCB1—Prednisolone—psoriasis	0.00617	0.00808	CbGbCtD
Quinidine—ABCB1—Hydrocortisone—psoriasis	0.00585	0.00766	CbGbCtD
Quinidine—ABCB1—Prednisone—psoriasis	0.00583	0.00763	CbGbCtD
Quinidine—CYP2C9—Cyclosporine—psoriasis	0.00569	0.00745	CbGbCtD
Quinidine—ABCB1—Cyclosporine—psoriasis	0.00553	0.00723	CbGbCtD
Quinidine—CYP2C8—Dexamethasone—psoriasis	0.00538	0.00703	CbGbCtD
Quinidine—CYP2D6—Cyclosporine—psoriasis	0.00521	0.00681	CbGbCtD
Quinidine—CYP3A4—Cholecalciferol—psoriasis	0.00504	0.00659	CbGbCtD
Quinidine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00437	0.00572	CbGbCtD
Quinidine—CYP3A4—Triamcinolone—psoriasis	0.00437	0.00572	CbGbCtD
Quinidine—CYP2C9—Dexamethasone—psoriasis	0.00375	0.00491	CbGbCtD
Quinidine—CYP3A4—Betamethasone—psoriasis	0.00375	0.0049	CbGbCtD
Quinidine—CYP3A4—Prednisolone—psoriasis	0.0037	0.00484	CbGbCtD
Quinidine—ABCB1—Dexamethasone—psoriasis	0.00364	0.00476	CbGbCtD
Quinidine—CYP3A4—Hydrocortisone—psoriasis	0.00351	0.00459	CbGbCtD
Quinidine—CYP3A4—Prednisone—psoriasis	0.00349	0.00457	CbGbCtD
Quinidine—CYP2D6—Dexamethasone—psoriasis	0.00343	0.00449	CbGbCtD
Quinidine—CYP3A4—Cyclosporine—psoriasis	0.00331	0.00433	CbGbCtD
Quinidine—ABCB1—Methotrexate—psoriasis	0.00292	0.00383	CbGbCtD
Quinidine—CYP3A4—Dexamethasone—psoriasis	0.00218	0.00285	CbGbCtD
Quinidine—Nausea—Hydroxyurea—psoriasis	0.000105	0.000527	CcSEcCtD
Quinidine—Pruritus—Mycophenolic acid—psoriasis	0.000105	0.000526	CcSEcCtD
Quinidine—Shock—Hydrocortisone—psoriasis	0.000105	0.000525	CcSEcCtD
Quinidine—Myalgia—Triamcinolone—psoriasis	0.000105	0.000525	CcSEcCtD
Quinidine—Nervous system disorder—Hydrocortisone—psoriasis	0.000105	0.000524	CcSEcCtD
Quinidine—Eye disorder—Prednisone—psoriasis	0.000105	0.000523	CcSEcCtD
Quinidine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000105	0.000523	CcSEcCtD
Quinidine—Decreased appetite—Cyclosporine—psoriasis	0.000104	0.000522	CcSEcCtD
Quinidine—Tachycardia—Hydrocortisone—psoriasis	0.000104	0.000521	CcSEcCtD
Quinidine—Flushing—Prednisone—psoriasis	0.000104	0.000519	CcSEcCtD
Quinidine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000104	0.000519	CcSEcCtD
Quinidine—Skin disorder—Hydrocortisone—psoriasis	0.000104	0.000519	CcSEcCtD
Quinidine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000103	0.000516	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.000103	0.000516	CcSEcCtD
Quinidine—Renal failure—Methotrexate—psoriasis	0.000102	0.000512	CcSEcCtD
Quinidine—Angioedema—Dexamethasone—psoriasis	0.000102	0.000511	CcSEcCtD
Quinidine—Angioedema—Betamethasone—psoriasis	0.000102	0.000511	CcSEcCtD
Quinidine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000102	0.00051	CcSEcCtD
Quinidine—Anorexia—Hydrocortisone—psoriasis	0.000102	0.000509	CcSEcCtD
Quinidine—Diarrhoea—Mycophenolic acid—psoriasis	0.000102	0.000508	CcSEcCtD
Quinidine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000101	0.000506	CcSEcCtD
Quinidine—Immune system disorder—Prednisone—psoriasis	0.000101	0.000505	CcSEcCtD
Quinidine—Oedema—Triamcinolone—psoriasis	0.000101	0.000503	CcSEcCtD
Quinidine—Vertigo—Betamethasone—psoriasis	0.0001	0.000502	CcSEcCtD
Quinidine—Vertigo—Dexamethasone—psoriasis	0.0001	0.000502	CcSEcCtD
Quinidine—Syncope—Dexamethasone—psoriasis	0.0001	0.000501	CcSEcCtD
Quinidine—Syncope—Betamethasone—psoriasis	0.0001	0.000501	CcSEcCtD
Quinidine—Sweating—Methotrexate—psoriasis	9.98e-05	0.000499	CcSEcCtD
Quinidine—Hypotension—Hydrocortisone—psoriasis	9.98e-05	0.000499	CcSEcCtD
Quinidine—Feeling abnormal—Cyclosporine—psoriasis	9.9e-05	0.000495	CcSEcCtD
Quinidine—Shock—Triamcinolone—psoriasis	9.89e-05	0.000495	CcSEcCtD
Quinidine—Gastrointestinal pain—Cyclosporine—psoriasis	9.83e-05	0.000491	CcSEcCtD
Quinidine—Loss of consciousness—Dexamethasone—psoriasis	9.83e-05	0.000491	CcSEcCtD
Quinidine—Loss of consciousness—Betamethasone—psoriasis	9.83e-05	0.000491	CcSEcCtD
Quinidine—Dizziness—Mycophenolic acid—psoriasis	9.82e-05	0.000491	CcSEcCtD
Quinidine—Tachycardia—Triamcinolone—psoriasis	9.82e-05	0.000491	CcSEcCtD
Quinidine—Mental disorder—Prednisone—psoriasis	9.8e-05	0.00049	CcSEcCtD
Quinidine—Erythema—Prednisone—psoriasis	9.74e-05	0.000487	CcSEcCtD
Quinidine—Malnutrition—Prednisone—psoriasis	9.74e-05	0.000487	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	9.73e-05	0.000487	CcSEcCtD
Quinidine—Hyperhidrosis—Triamcinolone—psoriasis	9.72e-05	0.000486	CcSEcCtD
Quinidine—Agranulocytosis—Methotrexate—psoriasis	9.72e-05	0.000486	CcSEcCtD
Quinidine—Convulsion—Dexamethasone—psoriasis	9.69e-05	0.000484	CcSEcCtD
Quinidine—Convulsion—Betamethasone—psoriasis	9.69e-05	0.000484	CcSEcCtD
Quinidine—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.66e-05	0.000483	CcSEcCtD
Quinidine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	9.59e-05	0.000479	CcSEcCtD
Quinidine—Urticaria—Cyclosporine—psoriasis	9.55e-05	0.000477	CcSEcCtD
Quinidine—Myalgia—Betamethasone—psoriasis	9.52e-05	0.000476	CcSEcCtD
Quinidine—Myalgia—Dexamethasone—psoriasis	9.52e-05	0.000476	CcSEcCtD
Quinidine—Abdominal pain—Cyclosporine—psoriasis	9.5e-05	0.000475	CcSEcCtD
Quinidine—Body temperature increased—Cyclosporine—psoriasis	9.5e-05	0.000475	CcSEcCtD
Quinidine—Vomiting—Mycophenolic acid—psoriasis	9.45e-05	0.000472	CcSEcCtD
Quinidine—Haemoglobin—Methotrexate—psoriasis	9.4e-05	0.00047	CcSEcCtD
Quinidine—Rash—Mycophenolic acid—psoriasis	9.37e-05	0.000468	CcSEcCtD
Quinidine—Dermatitis—Mycophenolic acid—psoriasis	9.36e-05	0.000468	CcSEcCtD
Quinidine—Hepatitis—Methotrexate—psoriasis	9.35e-05	0.000467	CcSEcCtD
Quinidine—Haemorrhage—Methotrexate—psoriasis	9.35e-05	0.000467	CcSEcCtD
Quinidine—Urticaria—Mycophenolate mofetil—psoriasis	9.31e-05	0.000466	CcSEcCtD
Quinidine—Headache—Mycophenolic acid—psoriasis	9.31e-05	0.000465	CcSEcCtD
Quinidine—Decreased appetite—Hydrocortisone—psoriasis	9.28e-05	0.000464	CcSEcCtD
Quinidine—Abdominal pain—Mycophenolate mofetil—psoriasis	9.27e-05	0.000463	CcSEcCtD
Quinidine—Body temperature increased—Mycophenolate mofetil—psoriasis	9.27e-05	0.000463	CcSEcCtD
Quinidine—Urinary tract disorder—Methotrexate—psoriasis	9.23e-05	0.000462	CcSEcCtD
Quinidine—Gastrointestinal disorder—Hydrocortisone—psoriasis	9.22e-05	0.000461	CcSEcCtD
Quinidine—Vision blurred—Prednisone—psoriasis	9.18e-05	0.000459	CcSEcCtD
Quinidine—Urethral disorder—Methotrexate—psoriasis	9.16e-05	0.000458	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Triamcinolone—psoriasis	9.16e-05	0.000458	CcSEcCtD
Quinidine—Oedema—Betamethasone—psoriasis	9.13e-05	0.000456	CcSEcCtD
Quinidine—Oedema—Dexamethasone—psoriasis	9.13e-05	0.000456	CcSEcCtD
Quinidine—Feeling abnormal—Prednisolone—psoriasis	9.01e-05	0.000451	CcSEcCtD
Quinidine—Visual impairment—Methotrexate—psoriasis	9.01e-05	0.000451	CcSEcCtD
Quinidine—Shock—Betamethasone—psoriasis	8.98e-05	0.000449	CcSEcCtD
Quinidine—Shock—Dexamethasone—psoriasis	8.98e-05	0.000449	CcSEcCtD
Quinidine—Dyspnoea—Triamcinolone—psoriasis	8.97e-05	0.000448	CcSEcCtD
Quinidine—Nervous system disorder—Dexamethasone—psoriasis	8.95e-05	0.000448	CcSEcCtD
Quinidine—Nervous system disorder—Betamethasone—psoriasis	8.95e-05	0.000448	CcSEcCtD
Quinidine—Agitation—Prednisone—psoriasis	8.95e-05	0.000447	CcSEcCtD
Quinidine—Thrombocytopenia—Betamethasone—psoriasis	8.93e-05	0.000447	CcSEcCtD
Quinidine—Thrombocytopenia—Dexamethasone—psoriasis	8.93e-05	0.000447	CcSEcCtD
Quinidine—Tachycardia—Betamethasone—psoriasis	8.91e-05	0.000445	CcSEcCtD
Quinidine—Tachycardia—Dexamethasone—psoriasis	8.91e-05	0.000445	CcSEcCtD
Quinidine—Angioedema—Prednisone—psoriasis	8.9e-05	0.000445	CcSEcCtD
Quinidine—Hypersensitivity—Cyclosporine—psoriasis	8.85e-05	0.000443	CcSEcCtD
Quinidine—Erythema multiforme—Methotrexate—psoriasis	8.84e-05	0.000442	CcSEcCtD
Quinidine—Nausea—Mycophenolic acid—psoriasis	8.82e-05	0.000441	CcSEcCtD
Quinidine—Hyperhidrosis—Dexamethasone—psoriasis	8.82e-05	0.000441	CcSEcCtD
Quinidine—Hyperhidrosis—Betamethasone—psoriasis	8.82e-05	0.000441	CcSEcCtD
Quinidine—Feeling abnormal—Hydrocortisone—psoriasis	8.8e-05	0.00044	CcSEcCtD
Quinidine—Vertigo—Prednisone—psoriasis	8.75e-05	0.000437	CcSEcCtD
Quinidine—Eye disorder—Methotrexate—psoriasis	8.74e-05	0.000437	CcSEcCtD
Quinidine—Gastrointestinal pain—Hydrocortisone—psoriasis	8.73e-05	0.000437	CcSEcCtD
Quinidine—Syncope—Prednisone—psoriasis	8.73e-05	0.000437	CcSEcCtD
Quinidine—Tinnitus—Methotrexate—psoriasis	8.72e-05	0.000436	CcSEcCtD
Quinidine—Anorexia—Betamethasone—psoriasis	8.7e-05	0.000435	CcSEcCtD
Quinidine—Anorexia—Dexamethasone—psoriasis	8.7e-05	0.000435	CcSEcCtD
Quinidine—Urticaria—Prednisolone—psoriasis	8.69e-05	0.000434	CcSEcCtD
Quinidine—Cardiac disorder—Methotrexate—psoriasis	8.68e-05	0.000434	CcSEcCtD
Quinidine—Hypersensitivity—Mycophenolate mofetil—psoriasis	8.64e-05	0.000432	CcSEcCtD
Quinidine—Asthenia—Cyclosporine—psoriasis	8.62e-05	0.000431	CcSEcCtD
Quinidine—Loss of consciousness—Prednisone—psoriasis	8.56e-05	0.000428	CcSEcCtD
Quinidine—Hypotension—Betamethasone—psoriasis	8.53e-05	0.000426	CcSEcCtD
Quinidine—Hypotension—Dexamethasone—psoriasis	8.53e-05	0.000426	CcSEcCtD
Quinidine—Pruritus—Cyclosporine—psoriasis	8.5e-05	0.000425	CcSEcCtD
Quinidine—Urticaria—Hydrocortisone—psoriasis	8.49e-05	0.000424	CcSEcCtD
Quinidine—Immune system disorder—Methotrexate—psoriasis	8.44e-05	0.000422	CcSEcCtD
Quinidine—Abdominal pain—Hydrocortisone—psoriasis	8.44e-05	0.000422	CcSEcCtD
Quinidine—Body temperature increased—Hydrocortisone—psoriasis	8.44e-05	0.000422	CcSEcCtD
Quinidine—Convulsion—Prednisone—psoriasis	8.44e-05	0.000422	CcSEcCtD
Quinidine—Mediastinal disorder—Methotrexate—psoriasis	8.43e-05	0.000421	CcSEcCtD
Quinidine—Asthenia—Mycophenolate mofetil—psoriasis	8.41e-05	0.000421	CcSEcCtD
Quinidine—Chills—Methotrexate—psoriasis	8.39e-05	0.000419	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.31e-05	0.000416	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Betamethasone—psoriasis	8.31e-05	0.000416	CcSEcCtD
Quinidine—Pruritus—Mycophenolate mofetil—psoriasis	8.29e-05	0.000415	CcSEcCtD
Quinidine—Myalgia—Prednisone—psoriasis	8.29e-05	0.000415	CcSEcCtD
Quinidine—Feeling abnormal—Triamcinolone—psoriasis	8.29e-05	0.000414	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	8.23e-05	0.000412	CcSEcCtD
Quinidine—Diarrhoea—Cyclosporine—psoriasis	8.22e-05	0.000411	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—psoriasis	8.19e-05	0.00041	CcSEcCtD
Quinidine—Erythema—Methotrexate—psoriasis	8.14e-05	0.000407	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—psoriasis	8.14e-05	0.000407	CcSEcCtD
Quinidine—Hypersensitivity—Prednisolone—psoriasis	8.06e-05	0.000403	CcSEcCtD
Quinidine—Diarrhoea—Mycophenolate mofetil—psoriasis	8.02e-05	0.000401	CcSEcCtD
Quinidine—Urticaria—Triamcinolone—psoriasis	7.99e-05	0.0004	CcSEcCtD
Quinidine—Body temperature increased—Triamcinolone—psoriasis	7.95e-05	0.000398	CcSEcCtD
Quinidine—Dizziness—Cyclosporine—psoriasis	7.95e-05	0.000397	CcSEcCtD
Quinidine—Oedema—Prednisone—psoriasis	7.95e-05	0.000397	CcSEcCtD
Quinidine—Decreased appetite—Betamethasone—psoriasis	7.93e-05	0.000397	CcSEcCtD
Quinidine—Decreased appetite—Dexamethasone—psoriasis	7.93e-05	0.000397	CcSEcCtD
Quinidine—Gastrointestinal disorder—Dexamethasone—psoriasis	7.88e-05	0.000394	CcSEcCtD
Quinidine—Gastrointestinal disorder—Betamethasone—psoriasis	7.88e-05	0.000394	CcSEcCtD
Quinidine—Hypersensitivity—Hydrocortisone—psoriasis	7.87e-05	0.000394	CcSEcCtD
Quinidine—Shock—Prednisone—psoriasis	7.82e-05	0.000391	CcSEcCtD
Quinidine—Nervous system disorder—Prednisone—psoriasis	7.79e-05	0.00039	CcSEcCtD
Quinidine—Tachycardia—Prednisone—psoriasis	7.76e-05	0.000388	CcSEcCtD
Quinidine—Dizziness—Mycophenolate mofetil—psoriasis	7.75e-05	0.000388	CcSEcCtD
Quinidine—Skin disorder—Prednisone—psoriasis	7.72e-05	0.000386	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisone—psoriasis	7.68e-05	0.000384	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—psoriasis	7.67e-05	0.000384	CcSEcCtD
Quinidine—Asthenia—Hydrocortisone—psoriasis	7.66e-05	0.000383	CcSEcCtD
Quinidine—Vomiting—Cyclosporine—psoriasis	7.64e-05	0.000382	CcSEcCtD
Quinidine—Rash—Cyclosporine—psoriasis	7.58e-05	0.000379	CcSEcCtD
Quinidine—Anorexia—Prednisone—psoriasis	7.58e-05	0.000379	CcSEcCtD
Quinidine—Dermatitis—Cyclosporine—psoriasis	7.57e-05	0.000379	CcSEcCtD
Quinidine—Pruritus—Hydrocortisone—psoriasis	7.56e-05	0.000378	CcSEcCtD
Quinidine—Headache—Cyclosporine—psoriasis	7.53e-05	0.000377	CcSEcCtD
Quinidine—Feeling abnormal—Betamethasone—psoriasis	7.52e-05	0.000376	CcSEcCtD
Quinidine—Feeling abnormal—Dexamethasone—psoriasis	7.52e-05	0.000376	CcSEcCtD
Quinidine—Gastrointestinal pain—Betamethasone—psoriasis	7.46e-05	0.000373	CcSEcCtD
Quinidine—Gastrointestinal pain—Dexamethasone—psoriasis	7.46e-05	0.000373	CcSEcCtD
Quinidine—Vomiting—Mycophenolate mofetil—psoriasis	7.45e-05	0.000373	CcSEcCtD
Quinidine—Hypersensitivity—Triamcinolone—psoriasis	7.41e-05	0.000371	CcSEcCtD
Quinidine—Rash—Mycophenolate mofetil—psoriasis	7.39e-05	0.00037	CcSEcCtD
Quinidine—Dermatitis—Mycophenolate mofetil—psoriasis	7.39e-05	0.000369	CcSEcCtD
Quinidine—Headache—Mycophenolate mofetil—psoriasis	7.34e-05	0.000367	CcSEcCtD
Quinidine—Vertigo—Methotrexate—psoriasis	7.31e-05	0.000366	CcSEcCtD
Quinidine—Diarrhoea—Hydrocortisone—psoriasis	7.31e-05	0.000365	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—psoriasis	7.28e-05	0.000364	CcSEcCtD
Quinidine—Urticaria—Dexamethasone—psoriasis	7.25e-05	0.000363	CcSEcCtD
Quinidine—Urticaria—Betamethasone—psoriasis	7.25e-05	0.000363	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Prednisone—psoriasis	7.24e-05	0.000362	CcSEcCtD
Quinidine—Dizziness—Prednisolone—psoriasis	7.23e-05	0.000362	CcSEcCtD
Quinidine—Asthenia—Triamcinolone—psoriasis	7.22e-05	0.000361	CcSEcCtD
Quinidine—Abdominal pain—Betamethasone—psoriasis	7.21e-05	0.000361	CcSEcCtD
Quinidine—Body temperature increased—Betamethasone—psoriasis	7.21e-05	0.000361	CcSEcCtD
Quinidine—Abdominal pain—Dexamethasone—psoriasis	7.21e-05	0.000361	CcSEcCtD
Quinidine—Body temperature increased—Dexamethasone—psoriasis	7.21e-05	0.000361	CcSEcCtD
Quinidine—Nausea—Cyclosporine—psoriasis	7.14e-05	0.000357	CcSEcCtD
Quinidine—Pruritus—Triamcinolone—psoriasis	7.12e-05	0.000356	CcSEcCtD
Quinidine—Dizziness—Hydrocortisone—psoriasis	7.06e-05	0.000353	CcSEcCtD
Quinidine—Convulsion—Methotrexate—psoriasis	7.05e-05	0.000353	CcSEcCtD
Quinidine—Nausea—Mycophenolate mofetil—psoriasis	6.96e-05	0.000348	CcSEcCtD
Quinidine—Myalgia—Methotrexate—psoriasis	6.93e-05	0.000346	CcSEcCtD
Quinidine—Chest pain—Methotrexate—psoriasis	6.93e-05	0.000346	CcSEcCtD
Quinidine—Decreased appetite—Prednisone—psoriasis	6.91e-05	0.000345	CcSEcCtD
Quinidine—Rash—Prednisolone—psoriasis	6.9e-05	0.000345	CcSEcCtD
Quinidine—Dermatitis—Prednisolone—psoriasis	6.89e-05	0.000345	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.88e-05	0.000344	CcSEcCtD
Quinidine—Headache—Prednisolone—psoriasis	6.85e-05	0.000343	CcSEcCtD
Quinidine—Vomiting—Hydrocortisone—psoriasis	6.79e-05	0.00034	CcSEcCtD
Quinidine—Rash—Hydrocortisone—psoriasis	6.73e-05	0.000337	CcSEcCtD
Quinidine—Dermatitis—Hydrocortisone—psoriasis	6.73e-05	0.000336	CcSEcCtD
Quinidine—Confusional state—Methotrexate—psoriasis	6.7e-05	0.000335	CcSEcCtD
Quinidine—Headache—Hydrocortisone—psoriasis	6.69e-05	0.000335	CcSEcCtD
Quinidine—Dizziness—Triamcinolone—psoriasis	6.65e-05	0.000333	CcSEcCtD
Quinidine—Feeling abnormal—Prednisone—psoriasis	6.55e-05	0.000327	CcSEcCtD
Quinidine—Asthenia—Dexamethasone—psoriasis	6.55e-05	0.000327	CcSEcCtD
Quinidine—Asthenia—Betamethasone—psoriasis	6.55e-05	0.000327	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—psoriasis	6.51e-05	0.000326	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—psoriasis	6.5e-05	0.000325	CcSEcCtD
Quinidine—Gastrointestinal pain—Prednisone—psoriasis	6.5e-05	0.000325	CcSEcCtD
Quinidine—Nausea—Prednisolone—psoriasis	6.5e-05	0.000325	CcSEcCtD
Quinidine—Pruritus—Betamethasone—psoriasis	6.46e-05	0.000323	CcSEcCtD
Quinidine—Pruritus—Dexamethasone—psoriasis	6.46e-05	0.000323	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—psoriasis	6.45e-05	0.000323	CcSEcCtD
Quinidine—Hyperhidrosis—Methotrexate—psoriasis	6.42e-05	0.000321	CcSEcCtD
Quinidine—Vomiting—Triamcinolone—psoriasis	6.39e-05	0.00032	CcSEcCtD
Quinidine—Nausea—Hydrocortisone—psoriasis	6.34e-05	0.000317	CcSEcCtD
Quinidine—Rash—Triamcinolone—psoriasis	6.34e-05	0.000317	CcSEcCtD
Quinidine—Dermatitis—Triamcinolone—psoriasis	6.34e-05	0.000317	CcSEcCtD
Quinidine—Anorexia—Methotrexate—psoriasis	6.33e-05	0.000317	CcSEcCtD
Quinidine—Urticaria—Prednisone—psoriasis	6.31e-05	0.000316	CcSEcCtD
Quinidine—Headache—Triamcinolone—psoriasis	6.3e-05	0.000315	CcSEcCtD
Quinidine—Abdominal pain—Prednisone—psoriasis	6.28e-05	0.000314	CcSEcCtD
Quinidine—Body temperature increased—Prednisone—psoriasis	6.28e-05	0.000314	CcSEcCtD
Quinidine—Diarrhoea—Betamethasone—psoriasis	6.24e-05	0.000312	CcSEcCtD
Quinidine—Diarrhoea—Dexamethasone—psoriasis	6.24e-05	0.000312	CcSEcCtD
Quinidine—Hypotension—Methotrexate—psoriasis	6.21e-05	0.00031	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—psoriasis	6.05e-05	0.000303	CcSEcCtD
Quinidine—Dizziness—Dexamethasone—psoriasis	6.03e-05	0.000302	CcSEcCtD
Quinidine—Dizziness—Betamethasone—psoriasis	6.03e-05	0.000302	CcSEcCtD
Quinidine—Nausea—Triamcinolone—psoriasis	5.97e-05	0.000299	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—psoriasis	5.92e-05	0.000296	CcSEcCtD
Quinidine—Hypersensitivity—Prednisone—psoriasis	5.86e-05	0.000293	CcSEcCtD
Quinidine—Vomiting—Dexamethasone—psoriasis	5.8e-05	0.00029	CcSEcCtD
Quinidine—Vomiting—Betamethasone—psoriasis	5.8e-05	0.00029	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—psoriasis	5.77e-05	0.000289	CcSEcCtD
Quinidine—Rash—Dexamethasone—psoriasis	5.75e-05	0.000288	CcSEcCtD
Quinidine—Rash—Betamethasone—psoriasis	5.75e-05	0.000288	CcSEcCtD
Quinidine—Dermatitis—Betamethasone—psoriasis	5.75e-05	0.000287	CcSEcCtD
Quinidine—Dermatitis—Dexamethasone—psoriasis	5.75e-05	0.000287	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—psoriasis	5.73e-05	0.000287	CcSEcCtD
Quinidine—Headache—Betamethasone—psoriasis	5.72e-05	0.000286	CcSEcCtD
Quinidine—Headache—Dexamethasone—psoriasis	5.72e-05	0.000286	CcSEcCtD
Quinidine—Asthenia—Prednisone—psoriasis	5.7e-05	0.000285	CcSEcCtD
Quinidine—Pruritus—Prednisone—psoriasis	5.62e-05	0.000281	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—psoriasis	5.47e-05	0.000274	CcSEcCtD
Quinidine—Diarrhoea—Prednisone—psoriasis	5.44e-05	0.000272	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—psoriasis	5.43e-05	0.000272	CcSEcCtD
Quinidine—Nausea—Betamethasone—psoriasis	5.42e-05	0.000271	CcSEcCtD
Quinidine—Nausea—Dexamethasone—psoriasis	5.42e-05	0.000271	CcSEcCtD
Quinidine—Urticaria—Methotrexate—psoriasis	5.28e-05	0.000264	CcSEcCtD
Quinidine—Dizziness—Prednisone—psoriasis	5.26e-05	0.000263	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—psoriasis	5.25e-05	0.000263	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—psoriasis	5.25e-05	0.000263	CcSEcCtD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.13e-05	0.00144	CbGpPWpGaD
Quinidine—SLC22A5—Transmembrane transport of small molecules—CARM1—psoriasis	5.07e-05	0.00142	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	5.07e-05	0.00142	CbGpPWpGaD
Quinidine—Vomiting—Prednisone—psoriasis	5.05e-05	0.000253	CcSEcCtD
Quinidine—ABCB1—Allograft Rejection—IL4—psoriasis	5.03e-05	0.00141	CbGpPWpGaD
Quinidine—Rash—Prednisone—psoriasis	5.01e-05	0.000251	CcSEcCtD
Quinidine—Dermatitis—Prednisone—psoriasis	5.01e-05	0.00025	CcSEcCtD
Quinidine—Headache—Prednisone—psoriasis	4.98e-05	0.000249	CcSEcCtD
Quinidine—SCN5A—SIDS Susceptibility Pathways—CXCL8—psoriasis	4.96e-05	0.00139	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—HLA-B—psoriasis	4.91e-05	0.00138	CbGpPWpGaD
Quinidine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	4.91e-05	0.00138	CbGpPWpGaD
Quinidine—Hypersensitivity—Methotrexate—psoriasis	4.89e-05	0.000245	CcSEcCtD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.88e-05	0.00137	CbGpPWpGaD
Quinidine—SCN3A—Axon guidance—TYK2—psoriasis	4.87e-05	0.00137	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—CXCL8—psoriasis	4.81e-05	0.00135	CbGpPWpGaD
Quinidine—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	4.81e-05	0.00135	CbGpPWpGaD
Quinidine—Asthenia—Methotrexate—psoriasis	4.77e-05	0.000238	CcSEcCtD
Quinidine—Nausea—Prednisone—psoriasis	4.72e-05	0.000236	CcSEcCtD
Quinidine—Pruritus—Methotrexate—psoriasis	4.7e-05	0.000235	CcSEcCtD
Quinidine—SCN2A—Axon guidance—TYK2—psoriasis	4.68e-05	0.00131	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—IL10—psoriasis	4.68e-05	0.00131	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—CYP2S1—psoriasis	4.68e-05	0.00131	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—JUN—psoriasis	4.61e-05	0.00129	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—NDUFA5—psoriasis	4.59e-05	0.00129	CbGpPWpGaD
Quinidine—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	4.59e-05	0.00129	CbGpPWpGaD
Quinidine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	4.57e-05	0.00128	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—LEP—psoriasis	4.56e-05	0.00128	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—HLA-A—psoriasis	4.55e-05	0.00128	CbGpPWpGaD
Quinidine—Diarrhoea—Methotrexate—psoriasis	4.54e-05	0.000227	CcSEcCtD
Quinidine—SCN1A—Axon guidance—TYK2—psoriasis	4.52e-05	0.00127	CbGpPWpGaD
Quinidine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	4.5e-05	0.00126	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—HCAR2—psoriasis	4.5e-05	0.00126	CbGpPWpGaD
Quinidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.48e-05	0.00126	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—JUN—psoriasis	4.47e-05	0.00125	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—NFKB1—psoriasis	4.44e-05	0.00124	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	4.43e-05	0.00124	CbGpPWpGaD
Quinidine—Dizziness—Methotrexate—psoriasis	4.39e-05	0.00022	CcSEcCtD
Quinidine—SCN2A—Developmental Biology—LEP—psoriasis	4.38e-05	0.00123	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—NFKB1—psoriasis	4.3e-05	0.00121	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.28e-05	0.0012	CbGpPWpGaD
Quinidine—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	4.27e-05	0.0012	CbGpPWpGaD
Quinidine—Vomiting—Methotrexate—psoriasis	4.22e-05	0.000211	CcSEcCtD
Quinidine—SCN1A—Developmental Biology—LEP—psoriasis	4.22e-05	0.00118	CbGpPWpGaD
Quinidine—Rash—Methotrexate—psoriasis	4.19e-05	0.000209	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—psoriasis	4.18e-05	0.000209	CcSEcCtD
Quinidine—Headache—Methotrexate—psoriasis	4.16e-05	0.000208	CcSEcCtD
Quinidine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.16e-05	0.00117	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CCL20—psoriasis	4.13e-05	0.00116	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HCAR2—psoriasis	4.08e-05	0.00114	CbGpPWpGaD
Quinidine—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	4.07e-05	0.00114	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.03e-05	0.00113	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—PPARG—psoriasis	3.97e-05	0.00111	CbGpPWpGaD
Quinidine—Nausea—Methotrexate—psoriasis	3.95e-05	0.000197	CcSEcCtD
Quinidine—SLCO1B1—Metabolism—NDUFA5—psoriasis	3.93e-05	0.0011	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—VEGFA—psoriasis	3.91e-05	0.00109	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CYP2S1—psoriasis	3.9e-05	0.00109	CbGpPWpGaD
Quinidine—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	3.89e-05	0.00109	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—PPARG—psoriasis	3.81e-05	0.00107	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.79e-05	0.00106	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.79e-05	0.00106	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	3.74e-05	0.00105	CbGpPWpGaD
Quinidine—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	3.71e-05	0.00104	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—PPARG—psoriasis	3.68e-05	0.00103	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.66e-05	0.00103	CbGpPWpGaD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	3.65e-05	0.00102	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—NDUFA5—psoriasis	3.6e-05	0.00101	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—NDUFA5—psoriasis	3.6e-05	0.00101	CbGpPWpGaD
Quinidine—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	3.56e-05	0.000997	CbGpPWpGaD
Quinidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	3.48e-05	0.000976	CbGpPWpGaD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	3.48e-05	0.000976	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—TYK2—psoriasis	3.48e-05	0.000975	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—TNF—psoriasis	3.45e-05	0.000968	CbGpPWpGaD
Quinidine—SCN3A—Axon guidance—VEGFA—psoriasis	3.45e-05	0.000966	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—NDUFA5—psoriasis	3.35e-05	0.00094	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—TNF—psoriasis	3.35e-05	0.000938	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	3.34e-05	0.000938	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—TYK2—psoriasis	3.34e-05	0.000937	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CYP2S1—psoriasis	3.34e-05	0.000936	CbGpPWpGaD
Quinidine—SCN2A—Axon guidance—VEGFA—psoriasis	3.31e-05	0.000928	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.23e-05	0.000906	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—TYK2—psoriasis	3.22e-05	0.000903	CbGpPWpGaD
Quinidine—SCN1A—Axon guidance—VEGFA—psoriasis	3.19e-05	0.000895	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.19e-05	0.000895	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—TYK2—psoriasis	3.17e-05	0.00089	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	3.12e-05	0.000874	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.11e-05	0.000872	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CYP2S1—psoriasis	3.06e-05	0.000859	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CYP2S1—psoriasis	3.06e-05	0.000858	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—IFNG—psoriasis	3.04e-05	0.000852	CbGpPWpGaD
Quinidine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.03e-05	0.00085	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	2.97e-05	0.000834	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—LEP—psoriasis	2.97e-05	0.000832	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CYP2S1—psoriasis	2.85e-05	0.0008	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.83e-05	0.000792	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.82e-05	0.000792	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—IL6—psoriasis	2.79e-05	0.000781	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—NFKB1—psoriasis	2.71e-05	0.00076	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—IL6—psoriasis	2.7e-05	0.000757	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—NDUFA5—psoriasis	2.67e-05	0.000747	CbGpPWpGaD
Quinidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.65e-05	0.000743	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—NDUFA5—psoriasis	2.61e-05	0.000732	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—NFKB1—psoriasis	2.6e-05	0.00073	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—PPARG—psoriasis	2.59e-05	0.000725	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.56e-05	0.000717	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—NFKB1—psoriasis	2.51e-05	0.000704	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—NDUFA5—psoriasis	2.46e-05	0.00069	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—VEGFA—psoriasis	2.46e-05	0.00069	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.45e-05	0.000687	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—STAT3—psoriasis	2.44e-05	0.000683	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.42e-05	0.000678	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.42e-05	0.000678	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HCAR2—psoriasis	2.41e-05	0.000676	CbGpPWpGaD
Quinidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	2.4e-05	0.000673	CbGpPWpGaD
Quinidine—SCN3A—Axon guidance—IL6—psoriasis	2.38e-05	0.000668	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—JUN—psoriasis	2.38e-05	0.000667	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—VEGFA—psoriasis	2.36e-05	0.000663	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—STAT3—psoriasis	2.34e-05	0.000656	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CCL20—psoriasis	2.34e-05	0.000655	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.33e-05	0.000652	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.3e-05	0.000643	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.29e-05	0.000643	CbGpPWpGaD
Quinidine—SCN2A—Axon guidance—IL6—psoriasis	2.29e-05	0.000642	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.29e-05	0.000642	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—CARM1—psoriasis	2.28e-05	0.00064	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—VEGFA—psoriasis	2.28e-05	0.000639	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CYP2S1—psoriasis	2.27e-05	0.000635	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—TYK2—psoriasis	2.27e-05	0.000635	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NDUFA5—psoriasis	2.26e-05	0.000633	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—STAT3—psoriasis	2.26e-05	0.000633	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—VEGFA—psoriasis	2.25e-05	0.000629	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CYP2S1—psoriasis	2.22e-05	0.000622	CbGpPWpGaD
Quinidine—SCN1A—Axon guidance—IL6—psoriasis	2.21e-05	0.000619	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.14e-05	0.000599	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CCL20—psoriasis	2.12e-05	0.000595	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—TNF—psoriasis	2.11e-05	0.000591	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.1e-05	0.00059	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CYP2S1—psoriasis	2.09e-05	0.000587	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TAGAP—psoriasis	2.09e-05	0.000586	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.08e-05	0.000583	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.05e-05	0.000574	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—TNF—psoriasis	2.03e-05	0.000568	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—TNF—psoriasis	1.97e-05	0.000551	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NDUFA5—psoriasis	1.97e-05	0.000551	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.95e-05	0.000548	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—TNF—psoriasis	1.95e-05	0.000548	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CYP2S1—psoriasis	1.92e-05	0.000538	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CARM1—psoriasis	1.91e-05	0.000535	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NDUFA5—psoriasis	1.85e-05	0.000519	CbGpPWpGaD
Quinidine—CHRM2—G alpha (i) signalling events—CXCL8—psoriasis	1.84e-05	0.000517	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NDUFA5—psoriasis	1.84e-05	0.000515	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.83e-05	0.000512	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.78e-05	0.0005	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—TNF—psoriasis	1.78e-05	0.000499	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—NFKB1—psoriasis	1.77e-05	0.000495	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.75e-05	0.000491	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.74e-05	0.000489	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.71e-05	0.00048	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—IL6—psoriasis	1.7e-05	0.000477	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CYP2S1—psoriasis	1.67e-05	0.000469	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—IL6—psoriasis	1.63e-05	0.000458	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CARM1—psoriasis	1.63e-05	0.000457	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—VEGFA—psoriasis	1.6e-05	0.000449	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—STAT3—psoriasis	1.59e-05	0.000445	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—IL6—psoriasis	1.58e-05	0.000442	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CYP2S1—psoriasis	1.58e-05	0.000442	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NDUFA5—psoriasis	1.57e-05	0.00044	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CYP2S1—psoriasis	1.56e-05	0.000438	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—IL6—psoriasis	1.55e-05	0.000435	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.52e-05	0.000427	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CARM1—psoriasis	1.5e-05	0.00042	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CARM1—psoriasis	1.49e-05	0.000419	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.47e-05	0.000411	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.46e-05	0.00041	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—IL6—psoriasis	1.44e-05	0.000403	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—CAT—psoriasis	1.41e-05	0.000394	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CARM1—psoriasis	1.39e-05	0.00039	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—TNF—psoriasis	1.37e-05	0.000385	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP2S1—psoriasis	1.33e-05	0.000374	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.3e-05	0.000363	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCL20—psoriasis	1.25e-05	0.000351	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.25e-05	0.00035	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.21e-05	0.00034	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CAT—psoriasis	1.17e-05	0.000329	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.13e-05	0.000317	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CXCL8—psoriasis	1.12e-05	0.000313	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—IL6—psoriasis	1.11e-05	0.000311	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CARM1—psoriasis	1.11e-05	0.00031	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.1e-05	0.000308	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—APOE—psoriasis	1.09e-05	0.000306	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CARM1—psoriasis	1.08e-05	0.000304	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.03e-05	0.000289	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CARM1—psoriasis	1.02e-05	0.000287	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.01e-05	0.000282	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CAT—psoriasis	1e-05	0.000281	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.7e-06	0.000272	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.55e-06	0.000268	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PPARG—psoriasis	9.51e-06	0.000267	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CARM1—psoriasis	9.37e-06	0.000263	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CAT—psoriasis	9.21e-06	0.000258	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CAT—psoriasis	9.19e-06	0.000258	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—APOE—psoriasis	9.11e-06	0.000256	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.76e-06	0.000246	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CAT—psoriasis	8.57e-06	0.00024	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.56e-06	0.00024	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.18e-06	0.000229	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CARM1—psoriasis	8.16e-06	0.000229	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PPARG—psoriasis	7.94e-06	0.000223	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—APOE—psoriasis	7.79e-06	0.000218	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CARM1—psoriasis	7.69e-06	0.000216	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CARM1—psoriasis	7.63e-06	0.000214	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—APOE—psoriasis	7.15e-06	0.000201	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—APOE—psoriasis	7.14e-06	0.0002	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.13e-06	0.0002	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.99e-06	0.000196	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SOCS1—psoriasis	6.9e-06	0.000193	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CAT—psoriasis	6.81e-06	0.000191	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PPARG—psoriasis	6.79e-06	0.00019	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CAT—psoriasis	6.67e-06	0.000187	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—APOE—psoriasis	6.66e-06	0.000187	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—TYK2—psoriasis	6.58e-06	0.000184	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CARM1—psoriasis	6.52e-06	0.000183	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	6.31e-06	0.000177	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CAT—psoriasis	6.29e-06	0.000176	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PPARG—psoriasis	6.23e-06	0.000175	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PPARG—psoriasis	6.22e-06	0.000174	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.09e-06	0.000171	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PPARG—psoriasis	5.8e-06	0.000163	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CAT—psoriasis	5.76e-06	0.000162	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL8—psoriasis	5.73e-06	0.000161	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—APOE—psoriasis	5.29e-06	0.000148	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—APOE—psoriasis	5.18e-06	0.000145	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—LEP—psoriasis	5.09e-06	0.000143	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—APOE—psoriasis	5.09e-06	0.000143	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CARM1—psoriasis	5.03e-06	0.000141	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CAT—psoriasis	5.02e-06	0.000141	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—APOE—psoriasis	4.88e-06	0.000137	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	4.74e-06	0.000133	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CAT—psoriasis	4.73e-06	0.000133	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CAT—psoriasis	4.69e-06	0.000132	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PPARG—psoriasis	4.61e-06	0.000129	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PPARG—psoriasis	4.51e-06	0.000127	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—APOE—psoriasis	4.48e-06	0.000126	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PPARG—psoriasis	4.25e-06	0.000119	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CAT—psoriasis	4.01e-06	0.000112	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—APOE—psoriasis	3.9e-06	0.000109	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PPARG—psoriasis	3.9e-06	0.000109	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TYK2—psoriasis	3.89e-06	0.000109	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—APOE—psoriasis	3.68e-06	0.000103	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—APOE—psoriasis	3.64e-06	0.000102	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PPARG—psoriasis	3.4e-06	9.53e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL8—psoriasis	3.38e-06	9.49e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL6—psoriasis	3.22e-06	9.02e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PPARG—psoriasis	3.2e-06	8.98e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PPARG—psoriasis	3.17e-06	8.9e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—JUN—psoriasis	3.15e-06	8.82e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—APOE—psoriasis	3.11e-06	8.73e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CAT—psoriasis	3.09e-06	8.67e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NFKB1—psoriasis	3.03e-06	8.49e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VEGFA—psoriasis	2.75e-06	7.7e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—STAT3—psoriasis	2.72e-06	7.63e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PPARG—psoriasis	2.71e-06	7.61e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—APOE—psoriasis	2.4e-06	6.74e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPARG—psoriasis	2.09e-06	5.87e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—psoriasis	2.08e-06	5.82e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL6—psoriasis	1.9e-06	5.33e-05	CbGpPWpGaD
